Bio-Techne
TECH
#1405
Rank
$10.80 B
Marketcap
$68.29
Share price
-1.53%
Change (1 day)
-30.29%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of June 2023 : $0.45 B

According to Bio-Techne's latest financial reports the company's total debt is $0.45 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 2001 to 2023)

Total debt by year

Year Total debt Change
2022-06-30$0.32 B-22.49%
2021-06-30$0.42 B-2.99%
2020-06-30$0.43 B-14.18%
2019-06-30$0.50 B49.01%
2018-06-30$0.33 B-3.12%
2017-06-30$0.34 B161.59%
2016-06-30$0.13 B15.26%
2015-06-30$0.11 B796.4%
2014-06-30$12.94 M
2006-06-30$13.42 M-8.13%
2005-06-30$14.61 M-7.83%
2004-06-30$15.85 M-7.19%
2003-06-30$17.08 M-5.34%
2002-06-30$18.05 M-4.67%
2001-06-30$18.93 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
$34.00 B 7,374.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$16.78 B 3,588.64%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.78 B 4,687.62%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.87 B 4,268.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.88 B 315.00%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$21.91 M-95.18%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.19 B 163.51%๐Ÿ‡บ๐Ÿ‡ธ USA